Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales (including related party sales of $41,616 and $18,706 in the three months ended December 31, 2021 and 2020, respectively, and $72,538 and $38,421 in the six months ended December 31, 2021 and 2020, respectively)	$ 1,172,419	$ 830,306	$ 2,205,149	$ 1,592,556
Cost of sales (including related party purchases of $96,728 and $51,532 in the three months ended December 31, 2021 and 2020, respectively, and $184,415 and $110,392 in the six months ended December 31, 2021 and 2020, respectively)	1,008,676	694,211	1,903,267	1,326,546
Gross profit	163,743	136,095	301,882	266,010
Operating expenses:
Research and development	65,471	52,729	130,614	107,527
Sales and marketing	21,960	20,740	43,584	41,032
General and administrative	25,263	25,261	47,507	49,640
Total operating expenses	112,694	98,730	221,705	198,199
Income from operations	51,049	37,365	80,177	67,811
Other expense, net	(607)	(2,539)	(557)	(3,380)
Interest expense	(1,150)	(569)	(1,954)	(1,243)
Income before income tax provision	49,292	34,257	77,666	63,188
Income tax provision	(7,599)	(5,108)	(10,924)	(8,768)
Share of income (loss) from equity investee, net of taxes	239	(1,475)	627	(145)
Net income	$ 41,932	$ 27,674	$ 67,369	$ 54,275
Net income per common share:
Basic (in dollars per share)	$ 0.82	$ 0.54	$ 1.32	$ 1.05
Diluted (in dollars per share)	$ 0.78	$ 0.52	$ 1.27	$ 1.00
Weighted-average shares used in calculation of net income per common share:
Basic (in shares)	51,314	51,499	51,055	51,914
Diluted (in shares)	53,511	53,584	53,213	54,005